SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-226652
Filing Date
2022-08-23
Accepted
2022-08-22 19:20:16
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d393900ds3.htm S-3 170593
2 EX-5.1 d393900dex51.htm EX-5.1 12928
3 EX-23.2 d393900dex232.htm EX-23.2 1515
4 EX-FILING FEES d393900dexfilingfees.htm EX-FILING FEES 32048
5 GRAPHIC g393900g02r90.jpg GRAPHIC 2312
6 GRAPHIC g393900g21p16.jpg GRAPHIC 62573
7 GRAPHIC g393900g48w61.jpg GRAPHIC 3838
  Complete submission text file 0001193125-22-226652.txt   313394
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267013 | Film No.: 221184840
SIC: 2836 Biological Products, (No Diagnostic Substances)